Our results also confirm previous reports about the association of Ang-2 and VEGF-A levels with clinical markers of disease severity in COVID-19, namely, length of ICU stay and extent of lung disease (Pine et al., 2020; Smadja et al., 2020; Hultström et al., 2022). Here, VEGFA is linked to COVID-19.